[Linagliptin and bullous pemphigoid: the story continues]

Semergen. 2020 Jul-Aug;46(5):363-364. doi: 10.1016/j.semerg.2020.03.005. Epub 2020 May 22.

[Article in Spanish]

Authors

C Albaladejo Blanco¹, A Mayorga Criado², A Bellvert Ríos², J A Martín García²

Affiliations

¹ Centro de Atención Primaria Llefià (Badalona-6), Institut Català de la Salut, Badalona, Barcelona, España. Electronic address: [email protected].
² Centro de Atención Primaria Llefià (Badalona-6), Institut Català de la Salut, Badalona, Barcelona, España.

PMID: 32451167
DOI: 10.1016/j.semerg.2020.03.005

No abstract available

Publication types

Letter
Comment

MeSH terms

Diabetes Mellitus, Type 2*
Dipeptidyl-Peptidase IV Inhibitors*
Humans
Linagliptin
Pemphigoid, Bullous*

Substances

Dipeptidyl-Peptidase IV Inhibitors
Linagliptin